There Might Be Blood: A Scoping Review on Women ’s Responses to Contraceptive-Induced Menstrual Bleeding Changes

ConclusionsSubstantial variability exists around how women respond to CIMBCs; these responses are shaped by individual and social influences. Despite variation in responses across contexts and sub-populations, CIMBCs can impact multiple aspects of women ’s lives. Women’s responses to CIMBCs should be recognized as a key issue in contraceptive research, counseling, and product development, but may be underappreciated, despite likely – and potentially substantial – impacts on contraceptive discontinuation and unmet need for modern contracepti on.
Source: The Guttmacher Institute - Category: International Medicine & Public Health Authors: Source Type: news

Related Links:

CONCLUSIONS: The Portico TAVI system allows safe and effective treatment of aortic stenosis in patients at increased surgical risk. At 30 days, mortality was low, and good haemodynamic performance was indicated by low transvalvular gradient and a low rate of moderate or higher PVL. PMID: 30111522 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
CONCLUSIONS: In the EXCEL trial, PCI of LM disease with TRA was associated with comparable early and late clinical outcomes as TFA. PMID: 30111521 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
Lotta $$ flowing around health tech services this week. Jessica DaMassa asks me about Alphabet/Google putting $375m into Oscar, Best Buy $800m for GreatCall, no money for med school at NYU &pain for patients in a Netflix movie. All in Health in 2 point 00 minutes!–Matthew Holt
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Health in 2 point 00 Jessica DaMassa Matthew Holt Alphabet Best Buy GreatCall NY Med School Oscar Health Patient Safety Serena Williams The Bleeding Edge Verily Source Type: blogs
Venous thromboembolism accounts for significant morbidity and mortality in patients with acute medical illnesses requiring hospital admission. American College of Chest Physicians guidelines recommend prophylaxis with heparins as first line and mechanical methods as second line. The risk of major bleeding with anticoagulants is less than 1% and not significantly different between agents. Although data support the use of all heparins, there is a trend toward superiority of low-molecular-weight heparins (LMWHs). Because acute illness and immobility do not end at hospital discharge, extended-duration therapy with LMWHs and di...
Source: Clinics in Chest Medicine - Category: Respiratory Medicine Authors: Source Type: research
Overdiagnosis of venous thromboembolism is associated with increasing numbers of patient complications and health care burden. Multiple clinical tools exist to estimate the probability of pulmonary embolism and deep venous thrombosis. When used with d-dimer testing, these can further stratify venous thromboembolism risk to help inform the use of additional diagnostic testing. Although there are similar tools to estimate bleeding risk, these are not as well-validated and lack reliability.
Source: Clinics in Chest Medicine - Category: Respiratory Medicine Authors: Source Type: research
More aggressive therapy for acute pulmonary embolism beyond anticoagulation is indicated in patients at higher risk for mortality and morbidity, namely those suffering from massive and possibly submassive disease. Catheter-based thrombolysis, catheter-based mechanical thrombus debulking, or combinations of these offer opportunities for rapid clot reduction and clinical improvement with a lower bleeding risk than systemic thrombolysis and perhaps greater efficacy. Optimal low-dose regimens for direct thrombolysis have not been defined just as optimal techniques and devices for mechanical therapy have not been developed, und...
Source: Clinics in Chest Medicine - Category: Respiratory Medicine Authors: Source Type: research
November 10, 2017In the global health community, we often talk about reaching the “last mile”—generally those who live in the hardest-to-reach places of the world, farthest from the health services they need. But from the point of view of those families, the last mile is in fact the first mile.The global information and communications technology community seems to understand this more than we do in health. Studies  such as this look directly at first-mile issues—that is, “how connectivity looks, feels, and behaves from the subscriber's perspective. ” And researchers have done&n...
Source: IntraHealth International - Category: International Medicine & Public Health Authors: Source Type: news
Abstract A 20‐year‐old patient with 3 months of amenorrhea presented in the labor room with bleeding per vaginum and having experienced lower abdominal pain for 2 h. She had a history of difficult intercourse and prolonged menstrual flow. Inspection revealed a bleeding point over an obstructing membrane at the level of the vaginal introitus. Subsequent vaginal examination confirmed the diagnosis of microperforate hymen. Her urine pregnancy test was positive and an ultrasound examination revealed the presence of retained products of conception in the endometrial cavity. Hymenectomy was carried out to evacuate the r...
Source: Journal of Obstetrics and Gynaecology Research - Category: OBGYN Authors: Tags: Case Report Source Type: research
CONCLUSION: In anovulatory or oligo-ovulatory women treated with CC, we found no significant difference in endometrial thickness whether or not the use of CC was preceded by a withdrawal bleed induced by MPA. PMID: 27261222 [PubMed - as supplied by publisher]
Source: Journal of Obstetrics and Gynaecology Canada : JOGC - Category: OBGYN Tags: J Obstet Gynaecol Can Source Type: research
Conclusion To conclude, 6 months therapy with 50 mg of mifepristone given weekly is efficacious and acceptable for the treatment of symptomatic leiomyoma, especially in a select group of patients. Although its use as a primary medical therapy is limited due to recurrence of fibroid after stopping treatment, it is useful for perimenopausal women whose myoma would regress after menopause, and younger infertile patients with small-size deep intramural myomas not easily accessible to either hysteroscopic or laparoscopic surgery. It is also beneficial as a preoperative adjunct, in patients with preoperative ...
Source: The Journal of Obstetrics and Gynecology of India - Category: OBGYN Source Type: research
More News: African Health | Amenorrhea | Bleeding | Infertility | International Medicine & Public Health | Men | Reproduction Medicine | Sports Medicine | Study | Women